Summer Sale

50% off Premium Yearly

00days
00hrs
00mins
00secs
Stockchase Opinions

Ryan BushellSavaria CorpSIS.TOPAST TOP PICKJun 25, 2021

(A Top Pick Jun 05/20, Up 48%) A good year for Savaria. Likes it a lot. The pandemic has helped their prospects. The demographics of aging is supportive of the company. Used the stock market panic to step in. There is now a rebound in general market confidence as well with demographic trends. Increasing scale and geographical footprint. More to come from this company.
$19.56

Stock price when the opinion was issued

$28.89

As of Jun 19, 2026. Market Open.

other services
It's the ideal tool to help you make quicker, more informed decisions for managing and tracking your investments.

You might be interested:

TOP PICK

It is a global leader in home accessibility equipment and patient handling. A concern in the second quarter report gave the stock a hit but he considers it a one-time event. Also it did a recent equity issue which is being used to pay down debt. It has good management, strong organic sales growth. a good backlog and improving margins. It should be able to make good acquisitions. Trades at 9X EBITDA, near historical lows.  
Buy 8  Hold 0  Sell 0

(Analysts’ price target is $20.71)
PAST TOP PICK
(A Top Pick Jun 06/22, Up 18%)

Great Q1 results. Strong organic growth, margins improved, record backlog for the rest of the year. 10x EBITDA, very reasonable. Good demographics. Targeting $1B in sales by 2025, tremendous upside if they can reach that goal. A better play than cost-intensive LTC homes. Yield is 3.1%.

BUY
Allan Tong’s Discover Picks

Savaria’s revenues have grown from $120 million in 2016 to $661 million in 2021 (the last reported full year). Accordingly, operating income has also climbed from $18.19 million to $49.18 million in the same time frame. However, the same cannot be said of net income, which was $12.3 million in 2016, then topped $26.46 million in 2020 but then fell to $11.54 million in 2021. Read: Canadian Tire, Savaria & XLI

HOLD

Trevor Rose’s Insights - Trevor’s most-liked answers from 5i Research. Stay at home trends support business. Stable fundamentals with growth expected. Debt trending lower. Higher valuation historically. Unlock Premium - Try 5i Free

BUY
Historically, it's done very well by growing by acquisition and organically. We're seeing ramp-up in demand from aging baby boomers that will push demand for Savaria's products. They pay a nice, growing dividend. It trades at a decent valuation. Their last quarter was good. But it's a small-cap company so prone to volatility.
BUY

Trevor Rose’s Insights - Trevor’s most-liked answers from 5i Research. Solid cash flow profile. Industry tailwinds strong. Diversified geographically and product line. Improved valuations. Unlock Premium - Try 5i Free

HOLD

Trevor Rose’s Insights - Trevor’s most-liked answers from 5i Research. Missed quarterly projections. Price increases just went into effect. Volume backlog in Toronto 3x last year. Margin expansion a goal. Unlock Premium - Try 5i Free

STRONG BUY
World's largest in home accessibility and patient handling. Aging demographic tailwinds. Very well managed. Margin compression from supply chain issues. Anticipates good execution. Business is booming.
WATCH
Management has lots of skin in the game. Challenges over Covid gaining access to LTC homes. Input costs have increased. Wants to see margins stabilize before getting back in. Don't rush to buy until you see that for a couple more quarters. Likes the fundamentals. Aging population provides a tailwind.
TOP PICK
Transformative acquisition last year made them largest player in sector. Record backlog of orders. Management suggesting record financial results for the coming year. Stock price down 30% is presenting excellent price to buy. Aging population providing tailwinds on business model.
HOLD

Billy Kawasaki’s Insights - Billy’s most-liked answers from 5i Research. The stock is down 12% YTD but 5i remains comfortable with it. It is not the only stock to have a tough year so far. Not a lot of choice in the sector. Potential is still good. Unlock Premium - Try 5i Free

PAST TOP PICK
(A Top Pick Aug 10/20, Up 5.35%) Expects demand for long term care facilities to increase. Has sold shares in company. If management team meets guidance, will be a good stock to buy. Wait to buy more shares.
PARTIAL BUY
He owned this until last year, selling it because the PE got high. This stock depends on aging demographics. For this reason, he's keeping it on his radar. Not a bad choice for your portfolio.
PAST TOP PICK
(A Top Pick Apr 28/21, Down 2.9%) They made a transformative acquisition of Sweden's Handicare to make Savaria the largest player in this space--major synergies. A few days ago they reported a very good quarter: surpassed $100 million EBITDA target, a record backlog, and are guiding $120-130 million EBITDA in 2022, an increase of 14%. The stock has fallen 20% from its highs, but now is a very good entry point--he is buying at these levels. Aging demographics are a strong tailwind as seniors prefer to stay at home longer and not move into long-term care. Well-managed and trades at a reasonable valuation.
HOLD

Billy Kawasaki’s Insights - Billy’s most-liked answers from 5i Research. Could continue to hold for income and growth. The valuation is more moderate at 21x earnings. The higher debt they took on over the last year is probably the cause. Less attractive than before. Growth is expected to be good and it could recover in a better market. Unlock Premium - Try 5i Free